These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36396650)

  • 1. Activation and signaling mechanism revealed by GPR119-G
    Qian Y; Wang J; Yang L; Liu Y; Wang L; Liu W; Lin Y; Yang H; Ma L; Ye S; Wu S; Qiao A
    Nat Commun; 2022 Nov; 13(1):7033. PubMed ID: 36396650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119.
    Hassing HA; Fares S; Larsen O; Pad H; Hauge M; Jones RM; Schwartz TW; Hansen HS; Rosenkilde MM
    Biochem Pharmacol; 2016 Nov; 119():66-75. PubMed ID: 27569424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of human GPR119-G
    Li R; Qian Y; Wang J; Han Z; Ye S; Wu S; Qiao A
    Front Pharmacol; 2024; 15():1310231. PubMed ID: 38288442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Determinant Underlying Selective Coupling of Primary G-Protein by Class A GPCRs.
    Shen Q; Tang X; Wen X; Cheng S; Xiao P; Zang SK; Shen DD; Jiang L; Zheng Y; Zhang H; Xu H; Mao C; Zhang M; Hu W; Sun JP; Zhang Y; Chen Z
    Adv Sci (Weinh); 2024 Jun; 11(23):e2310120. PubMed ID: 38647423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameterization of the GPR119 Receptor Agonist AR231453.
    Hamilton J; Kotsikorou E
    J Comput Chem; 2018 Jan; 39(1):35-41. PubMed ID: 29023843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular recognition of niacin and lipid-lowering drugs by the human hydroxycarboxylic acid receptor 2.
    Zhu S; Yuan Q; Li X; He X; Shen S; Wang D; Li J; Cheng X; Duan X; Xu HE; Duan J
    Cell Rep; 2023 Nov; 42(11):113406. PubMed ID: 37952153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of the ADGRG2-G
    Lin H; Xiao P; Bu RQ; Guo S; Yang Z; Yuan D; Zhu ZL; Zhang CX; He QT; Zhang C; Ping YQ; Zhao RJ; Ma CS; Liu CH; Zhang XN; Jiang D; Huang S; Xi YT; Zhang DL; Xue CY; Yang BS; Li JY; Lin HC; Zeng XH; Zhao H; Xu WM; Yi F; Liu Z; Sun JP; Yu X
    Nat Chem Biol; 2022 Nov; 18(11):1196-1203. PubMed ID: 35982227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural identification of lysophosphatidylcholines as activating ligands for orphan receptor GPR119.
    Xu P; Huang S; Guo S; Yun Y; Cheng X; He X; Cai P; Lan Y; Zhou H; Jiang H; Jiang Y; Xie X; Xu HE
    Nat Struct Mol Biol; 2022 Sep; 29(9):863-870. PubMed ID: 35970999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryo-EM structures of GPCRs coupled to G
    García-Nafría J; Tate CG
    Mol Cell Endocrinol; 2019 May; 488():1-13. PubMed ID: 30930094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained wash-resistant receptor activation responses of GPR119 agonists.
    Hothersall JD; Bussey CE; Brown AJ; Scott JS; Dale I; Rawlins P
    Eur J Pharmacol; 2015 Sep; 762():430-42. PubMed ID: 26101059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryo-EM structures of orphan GPR21 signaling complexes.
    Lin X; Chen B; Wu Y; Han Y; Qi A; Wang J; Yang Z; Wei X; Zhao T; Wu L; Xie X; Sun J; Zheng J; Zhao S; Xu F
    Nat Commun; 2023 Jan; 14(1):216. PubMed ID: 36639690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex.
    Krishna Kumar K; Shalev-Benami M; Robertson MJ; Hu H; Banister SD; Hollingsworth SA; Latorraca NR; Kato HE; Hilger D; Maeda S; Weis WI; Farrens DL; Dror RO; Malhotra SV; Kobilka BK; Skiniotis G
    Cell; 2019 Jan; 176(3):448-458.e12. PubMed ID: 30639101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.
    Ning Y; O'Neill K; Lan H; Pang L; Shan LX; Hawes BE; Hedrick JA
    Br J Pharmacol; 2008 Dec; 155(7):1056-65. PubMed ID: 18724386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A categorical structure-activity relationship analysis of GPR119 ligands.
    Kumar P; Carrasquer CA; Carter A; Song ZH; Cunningham AR
    SAR QSAR Environ Res; 2014; 25(11):891-903. PubMed ID: 25401513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-Dependent Activation of the Orphan G Protein-Coupled Receptor, GPR3.
    Russell IC; Zhang X; Bumbak F; McNeill SM; Josephs TM; Leeming MG; Christopoulos G; Venugopal H; Flocco MM; Sexton PM; Wootten D; Belousoff MJ
    Biochemistry; 2024 Mar; 63(5):625-631. PubMed ID: 38376112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR119: a promising target for nonalcoholic fatty liver disease.
    Yang JW; Kim HS; Im JH; Kim JW; Jun DW; Lim SC; Lee K; Choi JM; Kim SK; Kang KW
    FASEB J; 2016 Jan; 30(1):324-35. PubMed ID: 26399788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy.
    Im JH; Kang KW; Kim SY; Kim YG; An YJ; Park S; Jeong BH; Choi SY; Lee JS; Kang KW
    J Exp Clin Cancer Res; 2018 Nov; 37(1):295. PubMed ID: 30497501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features of activated GPCR signaling complexes.
    Wang J; Hua T; Liu ZJ
    Curr Opin Struct Biol; 2020 Aug; 63():82-89. PubMed ID: 32485565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional GPR119 Agonism Requires Peptide YY and Glucose for Activity in Mouse and Human Colon Mucosa.
    Tough IR; Forbes S; Herzog H; Jones RM; Schwartz TW; Cox HM
    Endocrinology; 2018 Apr; 159(4):1704-1717. PubMed ID: 29471473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPCRs steer G
    Huang S; Xu P; Shen DD; Simon IA; Mao C; Tan Y; Zhang H; Harpsøe K; Li H; Zhang Y; You C; Yu X; Jiang Y; Zhang Y; Gloriam DE; Xu HE
    Mol Cell; 2022 Jul; 82(14):2681-2695.e6. PubMed ID: 35714614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.